Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment

Area of Science:

• Biochemistry
• Pharmacology
• Oncology

Background:

• Selenium (Se)-containing compounds are increasingly recognized for their anticancer potential.
• These compounds exhibit high efficacy and selectivity against various cancer cells.
• Their cytotoxic effects often involve acting as pro-oxidants, disrupting cellular redox homeostasis.

Purpose of the Study:

• To review natural and synthetic organoselenium compounds with anticancer activity.
• To summarize recent advancements in understanding their molecular anticancer mechanisms.
• To highlight the therapeutic potential of organoselenium compounds in cancer treatment.

Main Methods:

• Literature review of natural and synthetic organoselenium compounds.
• Analysis of studies on their cytotoxic effects and mechanisms of action.
• Examination of their impact on cellular redox homeostasis and signaling pathways.

Main Results:

• Organoselenium compounds demonstrate significant antitumor activity, including metastasis prevention.
• Natural organoselenium compounds may possess fewer side effects compared to inorganic selenium compounds.
• The specific mechanisms of action and cell death pathways are dependent on the compound's chemical properties and the cancer model.

Conclusions:

• Organoselenium compounds represent a promising class of anticancer agents.
• Further research into their molecular mechanisms can facilitate the development of novel chemotherapeutics.
• Their potential for reduced systemic toxicity warrants continued investigation for clinical applications.